|
DVL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.446200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.008400E-01 |
| Normal-vs-Stage2 |
2.992600E-01 |
| Normal-vs-Stage3 |
1.659220E-01 |
| Normal-vs-Stage4 |
8.544600E-01 |
| Stage1-vs-Stage2 |
3.708800E-01 |
| Stage1-vs-Stage3 |
1.585400E-01 |
| Stage1-vs-Stage4 |
9.697200E-01 |
| Stage2-vs-Stage3 |
7.689000E-01 |
| Stage2-vs-Stage4 |
6.066000E-01 |
| Stage3-vs-Stage4 |
4.693800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.062200E-01 |
| Normal-vs-AfricanAmerican |
5.369000E-01 |
| Normal-vs-Asian |
4.145800E-01 |
| Caucasian-vs-AfricanAmerican |
6.244200E-01 |
| Caucasian-vs-Asian |
8.242600E-01 |
| AfricanAmerican-vs-Asian |
6.825000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.154000E-01 |
| Normal-vs-Female |
1.003530E-02 |
| Male-vs-Female |
4.180300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.884000E-01 |
| Normal-vs-Extreme_Weight |
9.571600E-01 |
| Normal-vs-Obese |
2.024800E-01 |
| Normal-vs-Extreme_Obese |
3.653600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.776800E-01 |
| Normal_Weight-vs-Obese |
3.942200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.983200E-01 |
| Extreme_Weight-vs-Obese |
9.058100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.458200E-01 |
| Obese-vs-Extreme_Obese |
9.424600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.105800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.305800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.934400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.752800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.396000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.754400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.923300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.062400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.096100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.169200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.068840E-01 |
| Normal-VS-Type2 PRCC |
4.221200E-01 |
| Normal-VS-KIRP CIMP |
4.799200E-03 |
| Normal-VS-Unclassified PRCC |
7.558200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.104980E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.218400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.786200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.923200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.297100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.310200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.005000E-01 |
| Normal-vs-N1 |
4.309700E-02 |
| Normal-vs-N2 |
1.354820E-01 |
| N0-vs-N1 |
1.192280E-02 |
| N0-vs-N2 |
3.204400E-01 |
| N1-vs-N2 |
7.525200E-01 |
|
|
